Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show
Marijuana Inc (OTCPINK:MAJI), operating as Exousia Pro, has received an order to deliver 500 billion dried exosomes for a trade show demonstration. The exosomes will be divided into 100 samples of 5 billion each and mixed into a cream to showcase a new product line.
The company is working with a partner serving over 300 clients (MedSpas and Dermatologist offices) who plans to transition from mammalian to plant-based exosomes in their products. The partner currently sells 1,500 bottles of hair serum monthly and aims to expand their product line using Exousia's mushroom exosomes.
Each 5 billion exosome order sells for $5.00 with a $2.00 manufacturing cost, resulting in a 60% profit margin. Exousia Pro claims to be the only company capable of producing dried plant-based exosomes, offering extended shelf life for medical and cosmeceutical applications.
Marijuana Inc (OTCPINK:MAJI), operante come Exousia Pro, ha ricevuto un ordine per la consegna di 500 miliardi di esomi secchi per una dimostrazione in fiera. Gli esomi saranno suddivisi in 100 campioni da 5 miliardi ciascuno e mescolati in una crema per presentare una nuova linea di prodotti.
L'azienda sta collaborando con un partner che serve oltre 300 clienti (MedSpas e studi dermatologici) che prevede di passare da esomi di origine mammifera a esomi vegetali nei propri prodotti. Attualmente, il partner vende 1.500 bottiglie di siero per capelli al mese e mira ad ampliare la propria linea di prodotti utilizzando gli esomi di funghi di Exousia.
Ogni ordine di 5 miliardi di esomi viene venduto a $5,00 con un costo di produzione di $2,00, risultando in un margine di profitto del 60%. Exousia Pro afferma di essere l'unica azienda in grado di produrre esomi vegetali secchi, offrendo una durata di conservazione prolungata per applicazioni mediche e cosmeceutiche.
Marijuana Inc (OTCPINK:MAJI), operando como Exousia Pro, ha recibido un pedido para entregar 500 mil millones de exosomas secos para una demostración en una feria. Los exosomas se dividirán en 100 muestras de 5 mil millones cada una y se mezclarán en una crema para presentar una nueva línea de productos.
La empresa está trabajando con un socio que atiende a más de 300 clientes (MedSpas y consultorios dermatológicos) que planea hacer la transición de exosomas de origen mamífero a exosomas de origen vegetal en sus productos. Actualmente, el socio vende 1,500 botellas de suero capilar al mes y tiene como objetivo expandir su línea de productos utilizando los exosomas de hongos de Exousia.
Cada pedido de 5 mil millones de exosomas se vende por $5.00 con un costo de fabricación de $2.00, lo que resulta en un margen de beneficio del 60%. Exousia Pro afirma ser la única empresa capaz de producir exosomas vegetales secos, ofreciendo una vida útil prolongada para aplicaciones médicas y cosmecéuticas.
Marijuana Inc (OTCPINK:MAJI), Exousia Pro로 운영되며, 무역 박람회 시연을 위해 5000억 개의 건조된 외소체를 배송하라는 주문을 받았습니다. 외소체는 각각 50억 개씩 100개의 샘플로 나뉘어 새로운 제품 라인을 선보이기 위해 크림에 혼합될 것입니다.
회사는 300명 이상의 고객(메드스파 및 피부과 사무실)을 대상으로 하는 파트너와 협력하고 있으며, 이 파트너는 제품에서 포유류에서 식물 기반 외소체로 전환할 계획입니다. 현재 이 파트너는 매달 1,500병의 헤어 세럼을 판매하고 있으며 Exousia의 버섯 외소체를 사용하여 제품 라인을 확장할 계획입니다.
각 50억 개 외소체 주문은 $5.00에 판매되며 제조 비용은 $2.00로, 60%의 이익률을 기록합니다. Exousia Pro는 의료 및 코스메슈티컬 응용을 위한 유통 기한이 연장된 건조 식물 기반 외소체를 생산할 수 있는 유일한 회사라고 주장합니다.
Marijuana Inc (OTCPINK:MAJI), opérant sous le nom de Exousia Pro, a reçu une commande pour livrer 500 milliards d'exosomes secs pour une démonstration lors d'un salon. Les exosomes seront divisés en 100 échantillons de 5 milliards chacun et mélangés dans une crème pour présenter une nouvelle gamme de produits.
L'entreprise travaille avec un partenaire qui dessert plus de 300 clients (MedSpas et cabinets de dermatologie) et qui prévoit de passer d'exosomes d'origine animale à des exosomes d'origine végétale dans ses produits. Le partenaire vend actuellement 1 500 bouteilles de sérum capillaire par mois et vise à élargir sa gamme de produits en utilisant les exosomes de champignons d'Exousia.
Chaque commande de 5 milliards d'exosomes se vend à 5,00 $ avec un coût de fabrication de 2,00 $, ce qui entraîne une marge bénéficiaire de 60%. Exousia Pro affirme être la seule entreprise capable de produire des exosomes végétaux secs, offrant une durée de conservation prolongée pour des applications médicales et cosméceutiques.
Marijuana Inc (OTCPINK:MAJI), das als Exousia Pro tätig ist, hat eine Bestellung zur Lieferung von 500 Milliarden getrockneten Exosomen für eine Messe-Demonstration erhalten. Die Exosomen werden in 100 Proben zu je 5 Milliarden unterteilt und in eine Creme gemischt, um eine neue Produktlinie zu präsentieren.
Das Unternehmen arbeitet mit einem Partner zusammen, der über 300 Kunden (MedSpas und dermatologische Praxen) betreut, und plant, von tierischen zu pflanzlichen Exosomen in seinen Produkten zu wechseln. Der Partner verkauft derzeit monatlich 1.500 Flaschen Haarserum und strebt an, sein Produktportfolio mit den Exosomen von Exousia zu erweitern.
Jede Bestellung von 5 Milliarden Exosomen wird für 5,00 $ verkauft, mit Herstellungskosten von 2,00 $, was zu einer Gewinnmarge von 60% führt. Exousia Pro behauptet, das einzige Unternehmen zu sein, das in der Lage ist, getrocknete pflanzliche Exosomen herzustellen, die eine verlängerte Haltbarkeit für medizinische und kosmetische Anwendungen bieten.
- 60% profit margin on exosome sales ($5 revenue vs $2 cost per 5 billion units)
- First-to-market position in plant-based exosomes for topical treatments
- Secured partnership with distributor serving 300+ medical clients
- Unique capability to produce dried plant-based exosomes with extended shelf life
- Revenue from core cancer treatment development still pending
- Early stage market entry with unproven commercial success
Exousia Pro has a
ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to announce that it has received an order to deliver 500 billion dried exosomes.
The order of 500 billion exosomes will be mixed into a cream and packaged into 100 samples containing 5 Billion Exosomes each. This will allow the marketing team to showcase a new product using exosomes. They will further demonstrate that exosomes do not alter the feel or consistency of their existing product, which is currently sold at large box stores nationwide. The marketing team will write orders at and after the show, and we anticipate larger orders to follow.
Exousia Pro is working with a company that services over 300 clients, including MedSpas and Dermatologist offices. They currently use mammalian exosomes but want to switch to plant-based to expand their sales channels for those who will not use mammalian for religious or ethical reasons. They sell 1,500 bottles of hair serum per month and plan to switch to plant-based exosomes, expanding their monthly sales volume and product line to feature new products using our mushroom exosomes.
An order of 5 billion exosomes would currently sell for
This order will showcase a significant feature Exousia Pro can offer: the ability to supply dried exosomes. By drying the exosomes, we can increase their shelf life. We believe Exousia Pro is the only Company currently able to produce and supply dried plant-based exosomes, which have many applications in the medical and cosmeceuticals markets.
Matt Dwyer, our President, stated, "Exousia Pro's primary focus is using its exosomes to create new treatments for the world's deadliest cancers. While this process is enriching, it can take time to achieve. During this time, we can use other sales channels to bring in revenue that will allow us to keep our focus on developing these new cancer treatments. We have several new sales channels we will be revealing soon. Using the feedback we receive from these early orders, along with testimonials and pictures, will make our entry into other markets much easier. Currently, no plant-based exosomes are being used in topical treatments, so we are first to market."
About Us
Exousia Pro is a clinical-stage biotechnology company developing new ways to exploit the therapeutic potential of exosomes, initially focused on oncology.The company's patented manufacturing process utilizes plant-based materials to create exosomes used in a number of commercial applications from dermatology to dentistry. The company's proprietary loading technology can infuse a range of molecules from drugs to DNA.
For more information, please visit: www.exousiapro.com
SAFE HARBOR
Forward-looking statements in this release are made under the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Exousia Pro, Inc.'s forward-looking statements do not guarantee future performance. This news release includes forward-looking statements concerning the parties' future level of business. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements due to certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of Exousia Pro, Inc., and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, appropriately price, retain, and complete projects and changes in products and competition.
CONTACT:
Marijuana, Inc.
www.Exousiapro.com
Twitter: @Exousia_Pro
Investor Relations
ir@exousiapro.com
SOURCE: Marijuana Inc.
View the original press release on ACCESS Newswire
FAQ
What is the profit margin for Exousia Pro's (MAJI) exosome products?
How many dried exosomes will MAJI deliver for the trade show demonstration?
What is the current monthly sales volume of MAJI's distribution partner?
What competitive advantage does Exousia Pro (MAJI) have in the exosome market?
How many clients does MAJI's new distribution partner serve?
